Literature DB >> 11745966

The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies.

T A Rando1.   

Abstract

Mutations of different components of the dystrophin-glycoprotein complex (DGC) cause muscular dystrophies that vary in terms of severity, age of onset, and selective involvement of muscle groups. Although the primary pathogenetic processes in the muscular dystrophies have clearly been identified as apoptotic and necrotic muscle cell death, the pathogenetic mechanisms that lead to cell death remain to be determined. Studies of components of the DGC in muscle and in nonmuscle tissues have revealed that the DGC is undoubtedly a multifunctional complex and a highly dynamic structure, in contrast to the unidimensional concept of the DGC as a mechanical component in the cell. Analysis of the DGC reveals compelling analogies to two other membrane-associated protein complexes, namely integrins and caveolins. Each of these complexes mediates signal transduction cascades in the cell, and disruption of each complex causes muscular dystrophies. The signal transduction cascades associated with the DGC, like those associated with integrins and caveolins, play important roles in cell survival signaling, cellular defense mechanisms, and regulation of the balance between cell survival and cell death. This review focuses on the functional components of the DGC, highlighting the evidence of their participation in cellular signaling processes important for cell survival. Elucidating the link between these functional components and the pathogenetic processes leading to cell death is the foremost challenge to understanding the mechanisms of disease expression in the muscular dystrophies due to defects in the DGC. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745966     DOI: 10.1002/mus.1192

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  102 in total

1.  The interaction with HMG20a/b proteins suggests a potential role for beta-dystrobrevin in neuronal differentiation.

Authors:  Benedetta Artegiani; Catherine Labbaye; Antonella Sferra; Maria Teresa Quaranta; Paola Torreri; Gianfranco Macchia; Marina Ceccarini; Tamara C Petrucci; Pompeo Macioce
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis.

Authors:  Kristen M Kallestad; Sadie L Hebert; Abby A McDonald; Mark L Daniel; Sharon R Cu; Linda K McLoon
Journal:  Exp Cell Res       Date:  2011-01-27       Impact factor: 3.905

Review 3.  Molecular substrates of potassium spatial buffering in glial cells.

Authors:  Paulo Kofuji; Nathan C Connors
Journal:  Mol Neurobiol       Date:  2003-10       Impact factor: 5.590

4.  α-Dystrobrevin distribution and association with other proteins in human promyelocytic NB4 cells treated for granulocytic differentiation.

Authors:  V V Borutinskaite; K-E Magnusson; R Navakauskiene
Journal:  Mol Biol Rep       Date:  2010-01-29       Impact factor: 2.316

Review 5.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

Review 6.  Are human and mouse satellite cells really the same?

Authors:  Luisa Boldrin; Francesco Muntoni; Jennifer E Morgan
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

Review 7.  Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Authors:  Nelsa L Estrella; Francisco J Naya
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

8.  Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.

Authors:  Adriana Pertille; Candida Luiza Tonizza de Carvalho; Cintia Yuri Matsumura; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

Review 9.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

Review 10.  The dystrobrevin-binding protein 1 gene: features and networks.

Authors:  A Y Guo; J Sun; B P Riley; D L Thiselton; K S Kendler; Z Zhao
Journal:  Mol Psychiatry       Date:  2008-07-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.